COMPANY

DEVELOPMENT AND MANUFACTURING OF BIOLOGIC DRUGS AND SECOND-GENERATION ADVANCED THERAPIES

DESCRIPTION

The Institute of Tissue Regenerative Medicine (IMERETI) is a biopharmaceutical GMP laboratory committed to the research, development and manufacture of biological drugs and second-generation advanced therapies related to regenerative and reparative medicine. In this sense, we manage the preclinical and clinical development, registration and marketing of cell therapies and tissue engineering. We also have quality control laboratories. IMERETI carries out research projects and clinical trials for the development of new personalized biological treatments, biomedical products and biomaterials for itself and for third parties related to regenerative medicine, born in the world of academia. Our developments are based on basic biomedical research, on the one hand, and on the other, on the development of the regulatory process and the offering of highly qualified and specialized services to third parties.